person

Miłosz D.

Country
Poland
Department
Oddział Kliniczny Intensywnej Terapii Kardiologicznej i Chorób Wewnętrznych

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 96 partner sites.

Specializations

Cardiovascular Medicine

Investigator’s work addresses acute coronary syndrome, various forms of heart failure, atrial fibrillation, resistant hypertension, and pulmonary arterial hypertension.

  • Acute Myocardial Infarction
  • Chronic Heart Failure
  • Atrial Fibrillation
  • Resistant Hypertension
  • Pulmonary Hypertension

All studies are conducted at the Uniwersytecki Szpital Kliniczny W Poznaniu.

Oncology – Solid Tumor Therapeutics

Research spans advanced breast cancer, non‑small cell lung cancer, renal cell carcinoma, and gastrointestinal malignancies, focusing on metastatic and refractory disease.

  • Metastatic Breast Cancer
  • Non‑Small Cell Lung Cancer
  • Renal Cell Carcinoma
  • Gastroesophageal Adenocarcinoma
  • Advanced Melanoma

Clinical trials evaluate novel targeted and immunotherapeutic strategies.

Hematologic Malignancies

Focus includes therapies for acute myeloid leukemia, various lymphomas, and multiple myeloma, particularly in relapsed or refractory settings.

  • Acute Myeloid Leukemia
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia

Investigations often combine cellular therapies with conventional regimens.

Metabolic, Obesity and Sleep Disorders

Studies address the impact of excess body weight and related conditions, including obesity and moderate to severe obstructive sleep apnea.

  • Obesity Management
  • Obstructive Sleep Apnea
  • Metabolic Syndrome
  • Weight‑Related Cardiovascular Risk
  • Sleep‑Related Breathing Disorders

Research evaluates therapeutic outcomes in overweight adult populations.

Rare and Genetic Disorders

Investigator explores hereditary and uncommon diseases such as transthyretin amyloid cardiomyopathy, Fabry disease, and other genetic cardiomyopathies.

  • Transthyretin Amyloid Cardiomyopathy
  • Fabry Disease
  • Hereditary Hemochromatosis
  • Congenital Adrenal Hyperplasia
  • Rare Pulmonary Hypertension Syndromes

Clinical programs aim to assess disease‑modifying interventions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.